Owners, management and financials
CVR: 25834844
Secondary names: FERTIN A/S, NordicCan A/S, NCP NextGen A/S
Previous names: JUT NR. 2128 A/S
DKK 1,344,394,000
Revenue
Net result: DKK -280,841,000
Aspeya Inc. (100%)
CVR · view owners
Michael Henrik Thomsen
Board: Christopher Beck Lambert (chair) and 6 members
CVR · view management
Active
Founded 2 January 2001
CVR · view overview
615 employees
CVR · 2018
Owner registered: Aspeya Inc.
CVR · 05/02/2026
View the full event history
FERTIN PHARMA A/S is a Danish company of the type Aktieselskab based in Vejle, founded in 2001. The company is registered under the industry Fremstilling af andre fødevarer i.a.n.. The company was previously named JUT NR. 2128 A/S. The management consists of Michael Henrik Thomsen. The board consists of Christopher Beck Lambert (chair), Bo Korsgaard Jensen, Lene Lind and Michael Henrik Thomsen. The company is owned by Aspeya Inc.. The company has 615 employees (2018). In 2025, the company reported revenue of DKK 1,344,394,000 and a net result of DKK -280,841,000 compared with DKK -259,011,000 the year before. Equity in the 2025 report amounted to DKK 1,269,900,000.
Source: annual report 2025, Danish Business Authority
Fertin Pharma A/S is experiencing a concerning trend in profitability, with consistent losses over the past four years, culminating in a net loss of 280.8 million DKK in 2025. Despite a significant increase in revenue from 892.6 million DKK in 2022 to 1.34 billion DKK in 2025, the company's ability to convert sales into profit remains a critical issue. The equity position has fluctuated, dropping from 1.5 billion DKK in 2024 to 1.27 billion DKK in 2025, indicating potential financial instability. As a player in the food manufacturing sector, the company must address its profitability challenges to strengthen its market position and ensure long-term viability.
AI-generated summary · Generated 04/07/2026
Selskabets formål er i eller uden for Danmark at drive industri og handelsvirksomhed samt virksomhed med kapitalanlæg eller anden virksomhed, der efter bestyrelsens skøn har tilknytning til disse formål.
Source: annual reports filed with the Danish Business Authority.
| Period | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | 1.3 mia. | -280.8 mio. | 3.4 mia. | 1.3 mia. | 1067 | |
| 202401/01/2024 – 31/12/2024 | 1.1 mia. | -259 mio. | 2.6 mia. | 1.5 mia. | 690 | |
| 202301/01/2023 – 31/12/2023 | 1 mia. | -136.7 mio. | 2.5 mia. | 458.4 mio. | 654 | |
| 202201/01/2022 – 31/12/2022 | 892.6 mio. | -91.4 mio. | 2.2 mia. | 596.3 mio. | 622 | |
| 202101/01/2021 – 31/12/2021 | 932.5 mio. | 37.6 mio. | 2 mia. | 681.4 mio. | 569 | |
| 202001/01/2020 – 31/12/2020 | 991.1 mio. | 155.4 mio. | 2 mia. | 770.1 mio. | 674 | |
| 201901/01/2019 – 31/12/2019 | 881.6 mio. | 81.3 mio. | 1.9 mia. | 778.3 mio. | 661 | |
| 201801/01/2018 – 31/12/2018 | 812.5 mio. | 45.8 mio. | 2 mia. | 896 mio. | 609 | |
| 201701/01/2017 – 31/12/2017 | 867.7 mio. | 106.4 mio. | 1.6 mia. | 770.5 mio. | 572 | |
| 201601/01/2016 – 31/12/2016 | 855.7 mio. | 100.1 mio. | 1.5 mia. | 659.6 mio. | 530 | |
| 201501/01/2015 – 31/12/2015 | 800.7 mio. | 64 mio. | 1.2 mia. | 560.9 mio. | 543 | |
| 201401/01/2014 – 31/12/2014 | 694.1 mio. | 42.2 mio. | 1 mia. | 495 mio. | 446 |
Compared to 168 companies in Fremstilling af andre fødevarer i.a.n.
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
4 properties
Upgrade to Pro to see addresses, building data and ownership details
Property report (PDF)
The entire property portfolio in one report: areas, usage, energy labels, flood exposure, planning zone and local plans.
See an example report (PDF)Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningThe CVR number of FERTIN PHARMA A/S is 25834844.
FERTIN PHARMA A/S is owned by Aspeya Inc..
The management of FERTIN PHARMA A/S consists of Michael Henrik Thomsen.
The board of FERTIN PHARMA A/S consists of Christopher Beck Lambert, Bo Korsgaard Jensen and Lene Lind, with Christopher Beck Lambert as chair.
In 2025, FERTIN PHARMA A/S reported revenue of DKK 1,344,394,000.
FERTIN PHARMA A/S had 615 employees in 2018 according to the Danish CVR register.
Claim this page to add your logo and social links. Free to get started.
FERTIN PHARMA A/S has published its annual report for 2025. Revenue came to DKK 1,344,394,000, and the net result was DKK -280,841,000.
As of February 5, 2026, is registered as an owner of FERTIN PHARMA A/S with an ownership share of 100%.
FERTIN PHARMA A/S has published its annual report for 2024. Revenue came to DKK 1,104,175,000, and the net result was DKK -259,011,000.
FERTIN PHARMA A/S has published its annual report for 2023. Revenue came to DKK 1,012,566,000, and the net result was DKK -136,701,000.
As of May 27, 2024, Gitte Lorenzen has joined the board of directors of FERTIN PHARMA A/S.
As of May 27, 2024, Stine Borup Hvam has joined the board of directors of FERTIN PHARMA A/S.
As of May 27, 2024, Anita Christensen Lindahl has joined the board of directors of FERTIN PHARMA A/S.
As of May 27, 2024, Bente Brændshøj has left the board of directors of FERTIN PHARMA A/S.
As of May 27, 2024, Peter Andreas Lund Dahl Jacobsen has left the board of directors of FERTIN PHARMA A/S.
As of May 26, 2024, Gitte Lorenzen has left the board of directors of FERTIN PHARMA A/S.
As of November 1, 2023, Christopher Beck Lambert has joined the board of directors of FERTIN PHARMA A/S.
As of November 1, 2023, Michael Henrik Thomsen has joined the board of directors of FERTIN PHARMA A/S.
As of November 1, 2023, Peter Halling has left the board of directors of FERTIN PHARMA A/S.
As of November 1, 2023, Michael Henrik Thomsen is registered as adm. dir. of FERTIN PHARMA A/S.
As of November 1, 2023, Peter Halling has stepped down as adm. dir. of FERTIN PHARMA A/S.
As of October 31, 2023, Michael Henrik Thomsen has left the board of directors of FERTIN PHARMA A/S.
FERTIN PHARMA A/S has published its annual report for 2022. Revenue came to DKK 892,580,000, and the net result was DKK -91,376,000.
FERTIN PHARMA A/S has published its annual report for 2021. Revenue came to DKK 932,545,000, and the net result was DKK 37,642,000.
As of May 27, 2022, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of FERTIN PHARMA A/S.
As of May 27, 2022, EY Godkendt Revisionspartnerselskab has stepped down as auditor of FERTIN PHARMA A/S.
As of September 15, 2021, Michael Henrik Thomsen has joined the board of directors of FERTIN PHARMA A/S.
As of September 15, 2021, Peter Andreas Lund Dahl Jacobsen has joined the board of directors of FERTIN PHARMA A/S.
As of September 15, 2021, Peter Halling has joined the board of directors of FERTIN PHARMA A/S.
As of September 15, 2021, Lene Lind has joined the board of directors of FERTIN PHARMA A/S.
As of September 15, 2021, Lars Bang has left the board of directors of FERTIN PHARMA A/S.
As of September 15, 2021, Claus Bagger-Sørensen has left the board of directors of FERTIN PHARMA A/S.
As of September 15, 2021, Rikke Kjær Nielsen has left the board of directors of FERTIN PHARMA A/S.
As of September 15, 2021, Carsten Skou has left the board of directors of FERTIN PHARMA A/S.
As of September 15, 2021, Manfred Scheske has left the board of directors of FERTIN PHARMA A/S.
As of September 15, 2021, Frank Charles Condella Jr has left the board of directors of FERTIN PHARMA A/S.
As of September 15, 2021, Marianne Kirkegaard Knudsen has left the board of directors of FERTIN PHARMA A/S.
As of September 14, 2021, Peter Andreas Lund Dahl Jacobsen has left the board of directors of FERTIN PHARMA A/S.
FERTIN PHARMA A/S has published its annual report for 2020. Revenue came to DKK 991,107,000, and the net result was DKK 155,411,000.
As of March 16, 2021, Betina Tandrup Moslund has left the board of directors of FERTIN PHARMA A/S.
As of August 1, 2020, Peter Halling is registered as adm. dir. of FERTIN PHARMA A/S.
As of August 1, 2020, Søren Birn has stepped down as adm. dir. of FERTIN PHARMA A/S.
FERTIN PHARMA A/S has published its annual report for 2019. Revenue came to DKK 881,616,000, and the net result was DKK 81,301,000.
As of September 1, 2019, Marianne Kirkegaard Knudsen has joined the board of directors of FERTIN PHARMA A/S.
As of September 1, 2019, Thomas Werner has left the board of directors of FERTIN PHARMA A/S.
FERTIN PHARMA A/S has published its annual report for 2018. Revenue came to DKK 812,500,000, and the net result was DKK 45,844,000.
As of May 15, 2019, Gitte Lorenzen has joined the board of directors of FERTIN PHARMA A/S.
As of May 15, 2019, Betina Tandrup Moslund has joined the board of directors of FERTIN PHARMA A/S.
As of May 15, 2019, Bente Brændshøj has joined the board of directors of FERTIN PHARMA A/S.
As of May 15, 2019, Peter Andreas Lund Dahl Jacobsen has joined the board of directors of FERTIN PHARMA A/S.
As of May 15, 2019, Carsten Skou has joined the board of directors of FERTIN PHARMA A/S.
As of May 15, 2019, Erik Bak Mortensen has left the board of directors of FERTIN PHARMA A/S.
As of May 15, 2019, Henrik Werner Lassen has left the board of directors of FERTIN PHARMA A/S.
As of May 14, 2019, Gitte Lorenzen has left the board of directors of FERTIN PHARMA A/S.
As of May 14, 2019, Betina Tandrup Moslund has left the board of directors of FERTIN PHARMA A/S.
As of May 14, 2019, Bente Brændshøj has left the board of directors of FERTIN PHARMA A/S.
As of September 13, 2018, Frank Charles Condella Jr has joined the board of directors of FERTIN PHARMA A/S.
As of August 1, 2018, Nikhilesh Singh has left the board of directors of FERTIN PHARMA A/S.
FERTIN PHARMA A/S has published its annual report for 2017. Revenue came to DKK 867,662,000, and the net result was DKK 106,353,000.
FERTIN PHARMA A/S has published its annual report for 2016. Revenue came to DKK 855,745,000, and the net result was DKK 100,073,000.
As of January 17, 2017, Claus Bagger-Sørensen has joined the board of directors of FERTIN PHARMA A/S.
As of January 17, 2017, Rikke Kjær Nielsen has joined the board of directors of FERTIN PHARMA A/S.
As of January 17, 2017, Thomas Werner has joined the board of directors of FERTIN PHARMA A/S.
As of January 17, 2017, Nikhilesh Singh has joined the board of directors of FERTIN PHARMA A/S.
As of January 17, 2017, Manfred Scheske has joined the board of directors of FERTIN PHARMA A/S.
As of January 17, 2017, Erik Gregers Hansen has left the board of directors of FERTIN PHARMA A/S.
As of January 17, 2017, Svend Andersen has left the board of directors of FERTIN PHARMA A/S.
As of January 17, 2017, Steen Bagger-Sørensen has left the board of directors of FERTIN PHARMA A/S.
As of January 17, 2017, Marianne Kock has left the board of directors of FERTIN PHARMA A/S.
As of January 16, 2017, Claus Bagger-Sørensen has left the board of directors of FERTIN PHARMA A/S.
FERTIN PHARMA A/S has published its annual report for 2015. Revenue came to DKK 800,654,000, and the net result was DKK 63,953,000.
As of September 17, 2015, Marianne Kock has joined the board of directors of FERTIN PHARMA A/S.
FERTIN PHARMA A/S has published its annual report for 2014. Revenue came to DKK 694,057,000, and the net result was DKK 42,229,000.
As of May 11, 2015, Gitte Lorenzen has joined the board of directors of FERTIN PHARMA A/S.
As of May 11, 2015, Betina Tandrup Moslund has joined the board of directors of FERTIN PHARMA A/S.
As of May 11, 2015, Svend Andersen has joined the board of directors of FERTIN PHARMA A/S.
As of May 11, 2015, Erik Bak Mortensen has joined the board of directors of FERTIN PHARMA A/S.
As of May 11, 2015, Henrik Werner Lassen has joined the board of directors of FERTIN PHARMA A/S.
As of May 11, 2015, Elsebeth Budolfsen has left the board of directors of FERTIN PHARMA A/S.
As of May 11, 2015, Jane Faltum has left the board of directors of FERTIN PHARMA A/S.
As of May 11, 2015, Ole Dalgaard Mikkelsen has left the board of directors of FERTIN PHARMA A/S.
FERTIN PHARMA A/S has published its annual report for 2013.
FERTIN PHARMA A/S has published its annual report for 2012.
As of January 7, 2013, Steen Bagger-Sørensen has joined the board of directors of FERTIN PHARMA A/S.
As of January 7, 2013, Claus Bagger-Sørensen has joined the board of directors of FERTIN PHARMA A/S.
As of January 7, 2013, Holger Bagger-Sørensen has left the board of directors of FERTIN PHARMA A/S.
As of August 30, 2010, Jane Faltum has joined the board of directors of FERTIN PHARMA A/S.
As of August 30, 2010, Ole Dalgaard Mikkelsen has joined the board of directors of FERTIN PHARMA A/S.
As of August 30, 2010, Bo Korsgaard Jensen has joined the board of directors of FERTIN PHARMA A/S.
As of August 30, 2010, Mette Lykke Baumgarten has left the board of directors of FERTIN PHARMA A/S.
As of August 30, 2010, Marianne Kirstine Hornbæk Bertelsen has left the board of directors of FERTIN PHARMA A/S.
As of August 30, 2010, Mogens Søndergaard Nielsen has left the board of directors of FERTIN PHARMA A/S.
As of May 20, 2010, Erik Gregers Hansen has joined the board of directors of FERTIN PHARMA A/S.
As of January 22, 2010, Søren Birn is registered as adm. dir. of FERTIN PHARMA A/S.
As of January 22, 2010, Lars Christian Nielsen has stepped down as adm. dir. of FERTIN PHARMA A/S.
As of May 20, 2009, Knud-Erik Borup has left the board of directors of FERTIN PHARMA A/S.
As of May 21, 2008, EY Godkendt Revisionspartnerselskab has been appointed auditor of FERTIN PHARMA A/S.
As of May 21, 2008, K P M G C JESPERSEN ÅRHUS I/S has stepped down as auditor of FERTIN PHARMA A/S.
As of January 31, 2007, Ralf Landrock Auerbach has stepped down as director of FERTIN PHARMA A/S.
As of May 30, 2006, Bente Brændshøj has joined the board of directors of FERTIN PHARMA A/S.
As of May 30, 2006, Marianne Kirstine Hornbæk Bertelsen has joined the board of directors of FERTIN PHARMA A/S.
As of May 30, 2006, Mogens Søndergaard Nielsen has joined the board of directors of FERTIN PHARMA A/S.
As of May 30, 2006, Lissi Nielsen has left the board of directors of FERTIN PHARMA A/S.
As of May 30, 2006, Marianne Lene Ørnsholt has left the board of directors of FERTIN PHARMA A/S.
As of January 1, 2006, Lars Christian Nielsen is registered as adm. dir. of FERTIN PHARMA A/S.
As of January 1, 2006, Ralf Landrock Auerbach is registered as director of FERTIN PHARMA A/S.
As of December 31, 2005, Lars Christian Hofman Funder-Schmidt has stepped down as director of FERTIN PHARMA A/S.
As of October 1, 2005, Lissi Nielsen has joined the board of directors of FERTIN PHARMA A/S.
As of September 30, 2005, Jesper Sandor Toth Mouritzen has left the board of directors of FERTIN PHARMA A/S.
As of September 30, 2005, Lissi Nielsen has left the board of directors of FERTIN PHARMA A/S.
As of May 22, 2003, Lars Bang has joined the board of directors of FERTIN PHARMA A/S.
As of October 25, 2002, Jesper Sandor Toth Mouritzen has joined the board of directors of FERTIN PHARMA A/S.
As of October 25, 2002, Lissi Nielsen has joined the board of directors of FERTIN PHARMA A/S.
As of October 25, 2002, Marianne Lene Ørnsholt has joined the board of directors of FERTIN PHARMA A/S.
As of October 25, 2002, Mette Lykke Baumgarten has joined the board of directors of FERTIN PHARMA A/S.
As of October 1, 2002, Christian Majgaard Nielsen has left the board of directors of FERTIN PHARMA A/S.
As of October 1, 2002, Lars Christian Nielsen has left the board of directors of FERTIN PHARMA A/S.
As of October 1, 2002, Jesper Strandskov has left the board of directors of FERTIN PHARMA A/S.
As of November 20, 2001, Knud-Erik Borup has joined the board of directors of FERTIN PHARMA A/S.
As of November 20, 2001, Christian Majgaard Nielsen has joined the board of directors of FERTIN PHARMA A/S.
As of November 20, 2001, Lars Christian Nielsen has joined the board of directors of FERTIN PHARMA A/S.
As of November 20, 2001, Elsebeth Budolfsen has joined the board of directors of FERTIN PHARMA A/S.
As of November 20, 2001, Jesper Strandskov has joined the board of directors of FERTIN PHARMA A/S.
As of November 20, 2001, Connie Astrup-Larsen has left the board of directors of FERTIN PHARMA A/S.
As of November 20, 2001, Hans-Henrik Horsted Eriksen has left the board of directors of FERTIN PHARMA A/S.
As of February 22, 2001, K P M G C JESPERSEN ÅRHUS I/S has been appointed auditor of FERTIN PHARMA A/S.
As of February 22, 2001, Poul Bak Revisionsfirma I/S Postboks 428 has stepped down as auditor of FERTIN PHARMA A/S.
As of February 22, 2001, Holger Bagger-Sørensen has joined the board of directors of FERTIN PHARMA A/S.
As of February 22, 2001, Connie Astrup-Larsen has joined the board of directors of FERTIN PHARMA A/S.
As of February 22, 2001, Hans-Henrik Horsted Eriksen has joined the board of directors of FERTIN PHARMA A/S.
As of February 22, 2001, Henrik Steen Jensen has left the board of directors of FERTIN PHARMA A/S.
As of February 22, 2001, Steffen Ebdrup has left the board of directors of FERTIN PHARMA A/S.
As of February 22, 2001, Erik Jensen has left the board of directors of FERTIN PHARMA A/S.
As of February 22, 2001, Lars Christian Hofman Funder-Schmidt is registered as director of FERTIN PHARMA A/S.
As of February 22, 2001, Erik Jensen has stepped down as director of FERTIN PHARMA A/S.
On February 22, 2001, the company changed its name from JUT NR. 2128 A/S to FERTIN PHARMA A/S.
As of January 2, 2001, Poul Bak Revisionsfirma I/S Postboks 428 has been appointed auditor of FERTIN PHARMA A/S.
As of January 2, 2001, Henrik Steen Jensen has joined the board of directors of FERTIN PHARMA A/S.
As of January 2, 2001, Steffen Ebdrup has joined the board of directors of FERTIN PHARMA A/S.
As of January 2, 2001, Erik Jensen has joined the board of directors of FERTIN PHARMA A/S.
As of January 2, 2001, Erik Jensen is registered as director of FERTIN PHARMA A/S.
FERTIN PHARMA A/S was founded on January 2, 2001.
Companies in the same industry and area
CVR 42202010
CVR 46082672
CVR 44059215
CVR 42686379
CVR 11802478
